Genetic Susceptibility to Breast and Ovarian Cancer
Publisher: American College of Medical Genetics 1999
Number of pages: 236
The Guidelines have been prepared to help the primary care provider to participate in the pre- and post-test education and counseling required for every patient contemplating genetic testing for breast and ovarian cancer. Although some important genetic, epidemiological, and clinical issues remain unresolved, it is essential that all health care providers understand the familial basis of some cancers and the potential applications of genetic testing as part of the risk assessment process.
Home page url
Download or read it online for free here:
by Kimberly K Vesco, et al. - Agency for Healthcare Research
This systematic review of cervical cancer screening focuses on when to begin screening and on updating test accuracy and harms data on liquid-based cytology (LBC) and human papillomavirus (HPV) testing, either alone or in combination with cytology.
- American Cancer Society
Breast cancer is a malignant tumor that starts from cells of the breast. A malignant tumor is a group of cancer cells that may grow into surrounding tissues or spread to distant areas of the body. This document refers only to breast cancer in women.
by F.C. Fernandes, L.M. Brasil, R. da Veiga (eds.) - InTech
Mammography remains at the backbone of medical tools to examine the human breast. The early detection of breast cancer typically uses adjunct tests to mammogram such as ultrasound, positron emission mammography, electrical impedance, and others.
by Nancy E. Adler, Ann E. K. Page - National Academies Press
Today, it is not possible to deliver high-quality cancer care without using existing approaches, tools, and resources to address patients' psychosocial health needs. This book recommends actions to ensure that this standard is met.